<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR27">
 <label>27.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Richardson</surname>
    <given-names>PG</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Phase 1 study of twice-weekly ixazomib, an oral proteasome inhibitor, in relapsed/refractory multiple myeloma patients</article-title>
  <source>Blood</source>
  <year>2014</year>
  <volume>124</volume>
  <fpage>1038</fpage>
  <lpage>1046</lpage>
  <pub-id pub-id-type="doi">10.1182/blood-2014-01-548826</pub-id>
  <?supplied-pmid 24920586?>
  <pub-id pub-id-type="pmid">24920586</pub-id>
 </element-citation>
</ref>
